After Prime Minister David Cameron commissioned Jim O’Neill in July 2014 to review the status of antimicrobial resistance, it has been reported that ‘Failure to tackle drug-resistant infections will lead to at least 10 million extra deaths a year and cost the global economy up to $100tn (£64tn) by 2050.’
The article continues to contextualise these figures, demonstrating that ‘there are currently 8.2 million deaths a year from cancer and annual global GDP stands at $70tn to $75tn, with the UK figure around $3tn.’
The review placed emphasis on researching the progress of 3 bacteria: carbapenem-resistant K pneumoniae (CRKP), Escherichia coli and Staphylococcus aureus (MRSA), but ‘also examined HIV, tuberculosis and malaria as broader public health issues for which resistance is a concern’.
‘The world’s most populous countries, India and China, face 2 million and 1 million deaths a year respectively by 2050 and one in every four deaths in Nigeria’, while currently the ‘“low estimate” of the current number of annual global deaths is put at 700,000’.
See:
Drug-resistant infections could lead to 10 million extra deaths a year